A2MC has just completed a 600 person trial in China on subjects with self reported lactose intolerance to see if there is any difference on their symptoms between A1/A2 milk and A2 only milk. This is a cleverly designed study as they know that up to 95% of Chinese have issues with dairy and it has always been hypothesised it was due to lactose intolerance. If the results of this 600 subject trial match the results of their earlier smaller study, it will give them huge advantage in China for all their products, imho.
https://clinicaltrials.gov/ct2/show/NCT02878876
The other study is also a potential game changer as they now start to fund a number of the areas where anacedotal evidence and incidental research has been strong, but formal trial data has not been available. This one examines the effects of A1 protein on ADHD and autistic children, aged between 5 and 10:
https://clinicaltrials.gov/show/NCT02911194
2 new studies from A2MC
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.92 |
Change
0.110(2.29%) |
Mkt cap ! $3.536B | |||
| Open | High | Low | Value | Volume |
| $4.82 | $4.94 | $4.79 | $5.278M | 1.080M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 16602 | $4.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.92 | 10105 | 12 |
View Market Depth
| Last trade - 15.04pm 18/11/2024 (20 minute delay) ? |
| A2M (ASX) Chart |